<DOC>
	<DOCNO>NCT00820521</DOCNO>
	<brief_summary>The purpose study assess safety tolerability ascend single oral dos GAP-134 healthy subject , provide initial pharmacokinetic profile oral formulation GAP-134 healthy subject , evaluate effect pharmacokinetic profile high-fat meal 450 mg GAP-134 administer healthy subject .</brief_summary>
	<brief_title>Study Evaluating Single Doses GAP-134</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Men woman nonchildbearing potential ( WONCBP ) age 18 50 year inclusive screening . WONCBP may include either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal ≥1 year ( follicle stimulate hormone [ FSH ] level ≥38 mIU/mL ) must negative pregnancy test result within 24 hour administration study drug placebo . Women surgically sterile must provide documentation procedure operative report ultrasound scan report . Sexually active men must agree use medically acceptable form contraception study continue use 12 week study drug placebo administration . Body mass index ( BMI ) range 18.0 30.0 kg/m2 body weight ≥50 kg . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign measurement , 12lead electrocardiogram ( ECG ) . Serum creatinine level must less 1.30 mg/dL . ( Normal range : 0.44 1.24 mg/dL . ) Nonsmoker smoker few 10 cigarette per day determine history . Must able abstain smoking inpatient stay . Exclusion Criteria Presence history disorder may prevent successful completion study . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . Any surgical medical condition may interfere absorption , distribution , metabolism , excretion study drug placebo . Acute disease state ( eg , nausea , vomit , fever , diarrhea ) within 7 day administration study drug placebo . Any history clinically important cardiac arrhythmia . Familial history long QT syndrome unexpected cardiac death . History drug abuse within 1 year administration study drug placebo .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>